Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOSUN INTL

4.000
+0.0100.25%
Volume:2.05M
Turnover:8.23M
Market Cap:32.73B
PE:-7.04
High:4.030
Open:3.990
Low:3.960
Close:3.990
Loading ...

Press Release: Fosun International Successfully Refinanced USD 870 Million Offshore Syndicated Loan

Dow Jones
·
28 Mar

Fosun Pharmaceutical-Owned Gland Pharma to Invest 1.6 Billion Yuan in Indian Mutual Funds, Bonds

MT Newswires Live
·
26 Mar

China's NAFMII Accepts Fosun Pharma's Application to Issue Up to 10 Billion Yuan Bonds

MT Newswires Live
·
26 Mar

Press Release: Fosun Pharma Announces 2024 Annual Results

Dow Jones
·
26 Mar

BRIEF-Fosun International Says FY Revenue From Operations For Shanghai Yuyuan Tourist Mart RMB46.92 Billion

Reuters
·
24 Mar

BRIEF-Fosun International Says FY Net Profit For Shanghai Yuyuan Tourist Mart Is RMB125.3 Million

Reuters
·
24 Mar

Fosun International - FY Revenue From Operations for Shanghai Yuyuan Tourist Mart RMB46.92 Bln

THOMSON REUTERS
·
24 Mar

Fosun International - FY Net Profit Attributable for Shanghai Yuyuan Tourist Mart (Group) RMB125.3 Mln

THOMSON REUTERS
·
24 Mar

BUZZ-India's Gland Pharma gains after Vanguard funds buy stake

Reuters
·
24 Mar

BUZZ-Indian shares may see $1.4 billion inflows as FTSE rejig comes into effect; ICICI Bank in focus

Reuters
·
21 Mar

Alligator Bioscience Announces FDA Orphan Drug Designation For HLX22/AC101

Reuters
·
20 Mar

Shanghai Henlius Biotech Says Orphan-Drug Designation Granted By US FDA

Reuters
·
19 Mar

Fosun Tourism Group to Delist After Share Buyback Receives Court's Approval

MT Newswires Live
·
17 Mar

Fosun International Unit to Divest Stake in E-commerce Firm

MT Newswires Live
·
17 Mar

Fosun International Ltd - Withdrawal of Ftg Shares Listing on Hkse Effective 19 March 2025

THOMSON REUTERS
·
17 Mar

Fosun International - Scheme Sanctioned by Grand Court and Became Effective on 14 March

THOMSON REUTERS
·
17 Mar

BRIEF-Fosun International Says Hangzhou Tianyuan Pet Products To Purchase 89.7145% Stake In Guangzhou Taotall Technology

Reuters
·
14 Mar

Shanghai Fosun Pharmaceutical (Group)'s Subsidiary PNH Drug Gets NMPA's Nod for Clinical Trials; Shares Rise 4%

MT Newswires Live
·
14 Mar

Fosun Pharma Gets Clinical Trial Approval for Blood Disorder Drug

MT Newswires Live
·
14 Mar

Fosun Pharmaceutical Selling Stake in Healthcare Firm for $124 Million

MT Newswires Live
·
14 Mar